GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Illumina Inc (NAS:ILMN) » Definitions » Shiller PE Ratio

ILMN (Illumina) Shiller PE Ratio : (As of Oct. 31, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Illumina Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Illumina Shiller PE Ratio Historical Data

The historical data trend for Illumina's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Illumina Shiller PE Ratio Chart

Illumina Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 104.52 103.65 89.04 133.12 199.08

Illumina Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 133.86 153.82 199.08 238.21 -

Competitive Comparison of Illumina's Shiller PE Ratio

For the Diagnostics & Research subindustry, Illumina's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Illumina's Shiller PE Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Illumina's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Illumina's Shiller PE Ratio falls into.



Illumina Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Illumina's E10 for the quarter that ended in Jun. 2024 is calculated as:

For example, Illumina's adjusted earnings per share data for the three months ended in Jun. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Jun. 2024 (Change)*Current CPI (Jun. 2024)
=-12.48/132.5538*132.5538
=-12.480

Current CPI (Jun. 2024) = 132.5538.

Illumina Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201409 0.630 100.428 0.832
201412 1.030 99.070 1.378
201503 0.920 99.621 1.224
201506 0.690 100.684 0.908
201509 0.790 100.392 1.043
201512 0.700 99.792 0.930
201603 0.600 100.470 0.792
201606 0.820 101.688 1.069
201609 0.870 101.861 1.132
201612 0.840 101.863 1.093
201703 2.480 102.862 3.196
201706 0.870 103.349 1.116
201709 1.110 104.136 1.413
201712 0.460 104.011 0.586
201803 1.410 105.290 1.775
201806 1.410 106.317 1.758
201809 1.330 106.507 1.655
201812 1.410 105.998 1.763
201903 1.570 107.251 1.940
201906 1.990 108.070 2.441
201909 1.580 108.329 1.933
201912 1.610 108.420 1.968
202003 1.170 108.902 1.424
202006 0.320 108.767 0.390
202009 1.210 109.815 1.461
202012 1.750 109.897 2.111
202103 1.000 111.754 1.186
202106 1.260 114.631 1.457
202109 2.080 115.734 2.382
202112 0.710 117.630 0.800
202203 0.550 121.301 0.601
202206 -3.400 125.017 -3.605
202209 -24.260 125.227 -25.680
202212 -0.890 125.222 -0.942
202303 0.020 127.348 0.021
202306 -1.480 128.729 -1.524
202309 -4.770 129.860 -4.869
202312 -1.110 129.419 -1.137
202403 -0.790 131.776 -0.795
202406 -12.480 132.554 -12.480

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Illumina  (NAS:ILMN) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Illumina Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Illumina's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Illumina Business Description

Address
5200 Illumina Way, San Diego, CA, USA, 92122
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2023 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Executives
Jacob Thaysen director, officer: Chief Executive Officer 5301 STEVENS CREEK BLVD., SANTA CLARA CA 95051
Aimee L Hoyt officer: SVP, Chief People Officer 5200 ILLUMINA WAY, SAN DIEGO CA 92122
Susan H Tousi officer: SVP Product Development 5200 ILLUMINA WAY, SAN DIEGO CA 92122
Steven Barnard officer: SVP, Chief Technology Officer 5200 ILLUMINA WAY, SAN DIEGO CA 92122
Scott B. Ullem director C/O EDWARDS LIFESCIENCES CORPORATION, ONE EDWARDS WAY, IRVINE CA 92614
Stephen P Macmillan director 250 CAMPUS DRIVE, MARLBOROUGH MA 01752
Andrew Teno director C/O FIR TREE INC., 55 WEST 46TH STREET, 29TH FLOOR, NEW YORK NY 10036
Alexander Aravanis officer: SVP, Chief Technology Officer 5200 ILLUMINA WAY, SAN DIEGO CA 92122
Scott D Ericksen officer: VP, Chief Accounting Officer 5200 ILLUMINA WAY, SAN DIEGO CA 92122
Charles Dadswell officer: Sr VP & General Counsel 5200 ILLUMINA WAY, SAN DIEGO CA 92122
John Edward Frank officer: Chief Public Affairs Officer 5200 ILLUMINA WAY, SAN DIEGO CA 92122
Phillip G. Febbo officer: SVP Chief Medical Officer C/O GENOMIC HEALTH, INC., 301 PENOBSCOT DRIVE, REDWOOD CITY CA 94063
Carissa Rollins officer: SVP, Chief Information Officer 5200 ILLUMINA WAY, SAN DIEGO CA 92122
Kevin Carl Pegels officer: Chief of Global Operations 5200 ILLUMINA WAY, SAN DIEGO CA 92122
Jay T Flatley officer: President & CEO 9885 TOWNE CENTRE DR, SAN DIEGO CA 92121